These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 29363862)
1. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer. Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862 [TBL] [Abstract][Full Text] [Related]
2. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. Hirata H; Ueno K; Shahryari V; Deng G; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R PLoS One; 2013; 8(1):e55502. PubMed ID: 23383207 [TBL] [Abstract][Full Text] [Related]
4. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E. Song Y; Song C; Yang S Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747 [TBL] [Abstract][Full Text] [Related]
5. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs. Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661 [TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer. Beveridge DJ; Richardson KL; Epis MR; Brown RAM; Stuart LM; Woo AJ; Leedman PJ Sci Rep; 2021 Sep; 11(1):18003. PubMed ID: 34504167 [TBL] [Abstract][Full Text] [Related]
7. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK. Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989 [TBL] [Abstract][Full Text] [Related]
8. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. Reis ST; Pontes-Junior J; Antunes AA; Dall'Oglio MF; Dip N; Passerotti CC; Rossini GA; Morais DR; Nesrallah AJ; Piantino C; Srougi M; Leite KR BMC Urol; 2012 May; 12():14. PubMed ID: 22642976 [TBL] [Abstract][Full Text] [Related]
9. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer. Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472 [TBL] [Abstract][Full Text] [Related]
10. The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect. Weng Y; Shen Y; He Y; Pan X; Xu J; Jiang Y; Zhang Q; Wang S; Kong F; Zhao S; Zhou D; Zhang Y Biochem Biophys Res Commun; 2018 Sep; 503(4):2749-2757. PubMed ID: 30093112 [TBL] [Abstract][Full Text] [Related]
11. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer. Xiang J; Bian C; Wang H; Huang S; Wu D J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908 [TBL] [Abstract][Full Text] [Related]
12. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo. Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903 [TBL] [Abstract][Full Text] [Related]
13. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells. Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737 [TBL] [Abstract][Full Text] [Related]
14. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691 [TBL] [Abstract][Full Text] [Related]
15. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676 [TBL] [Abstract][Full Text] [Related]
16. miR-539 inhibits prostate cancer progression by directly targeting SPAG5. Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000 [TBL] [Abstract][Full Text] [Related]
18. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4. Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117 [TBL] [Abstract][Full Text] [Related]
20. miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway. Liu S; Wang Q; Liu Y; Xia ZY J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]